Results of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM)

D. Peereboom, L. B. Nabors, P. Kumthekar, M. Badruddoja, K. Fink, F. Lieberman, S. Phuphanich, E. Dunbar, T. Walbert, D. Schiff, D. D. Tran, L. S. Ashby, N. Butowski, F. Iwamoto, R. Lindsay, J. Bullington, M. Schulder, J. Sherman, C. Brooks, D. Reardon

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii122-viii123
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this